Camptothecin enhances random integration of transfected DNA into the genome of mammalian cells

Citation
Og. Shcherbakova et Mv. Filatov, Camptothecin enhances random integration of transfected DNA into the genome of mammalian cells, BBA-MOL CEL, 1495(1), 2000, pp. 1-3
Citations number
14
Categorie Soggetti
Cell & Developmental Biology
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
ISSN journal
01674889 → ACNP
Volume
1495
Issue
1
Year of publication
2000
Pages
1 - 3
Database
ISI
SICI code
0167-4889(20000110)1495:1<1:CERIOT>2.0.ZU;2-M
Abstract
In order to study the involvement of DNA topoisomerase I (top1) in recombin ation, we examined the effect of the antineoplastic drug camptothecin, whic h selectively poisons top1 by trapping top1-cleavable complexes on integrat ion of exogenic vector into the genome of mammalian cells. We transfected m ouse F9 teratocarcinoma cells as well as Chinese hamster V79 cells with a p lasmid carrying a selectable neo gene treated with camptothecin, and determ ined the frequency of neo+ (G418(R)) colonies. We found that treatment with camptothecin for as short a time as 4 h after electroporation resulted in a 4- to 33-fold stimulation of plasmid integration into the recipient genom e via non-homologous recombination. These results imply that top1-cleavable complexes trapped by camptothecin could be potentially recombinogenic stru ctures and could stimulate non-homologous recombination in vivo, promoting the integration of transfected plasmids into mammalian genome. (C) 2000 Els evier Science B.V. All rights reserved.